Literature DB >> 29611039

Analysis of computed tomography density of liver before and after amiodarone administration.

Masazumi Matsuda1, Aoi Otaka2, Tomoki Tozawa2, Tomoyuki Asano2, Koichi Ishiyama2, Manabu Hashimoto2.   

Abstract

PURPOSE: To evaluate CT density of liver changes between before and after amiodarone administration.
MATERIALS AND METHODS: Twenty-five patients underwent non-enhanced CT including the liver before and after amiodarone administration. We set regions of interest (ROIs) at liver S8, spleen, paraspinal muscle, and calculated average CT density in these ROIs, then compared CT density between liver and other organs. Statistical differences between CT density of liver and various ratios before and after administration were determined, along with correlations between cumulative dose of amiodarone and liver density after administration, density change of liver, and various ratios after administration.
RESULTS: Liver density, liver-to-spleen ratio, and liver-to-paraspinal muscle ratio differed significantly between before and after amiodarone administration. No significant correlations were found between cumulative doses of amiodarone and any of liver density after administration, density change of liver, or various ratios after administration.
CONCLUSION: CT density of liver after amiodarone administration was significantly higher than that before administration. No correlations were identified between cumulative dose of amiodarone and either liver density after administration or density change of liver. Amiodarone usage should be checked when radiologists identify high density of the liver on CT.

Entities:  

Keywords:  Amiodarone; CT density of liver; Computed tomography

Mesh:

Substances:

Year:  2018        PMID: 29611039     DOI: 10.1007/s11604-018-0733-4

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  23 in total

1.  Amiodarone-induced liver cirrhosis and parkinsonism: a case report.

Authors:  S Ishida; M Sugino; T Hosokawa; T Sato; D Furutama; A Fukuda; F Kimura; H Kuwabara; Y Shibayama; T Hanafusa
Journal:  Clin Neuropathol       Date:  2010 Mar-Apr       Impact factor: 1.368

2.  Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology.

Authors:  N Goldschlager; A E Epstein; G Naccarelli; B Olshansky; B Singh
Journal:  Arch Intern Med       Date:  2000-06-26

3.  Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report.

Authors:  Hiroki Oikawa; Chihaya Maesawa; Ryo Sato; Kanta Oikawa; Hiroyuki Yamada; Seizo Oriso; Sadahide Ono; Akiko Yashima-Abo; Koji Kotani; Kazuyuki Suzuki; Tomoyuki Masuda
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

4.  Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.

Authors:  B N Singh; Y W Cho; H P Kuemmerle
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1981-05

Review 5.  Dual-energy CT applications in the abdomen.

Authors:  Tobias Heye; Rendon C Nelson; Lisa M Ho; Daniele Marin; Daniel T Boll
Journal:  AJR Am J Roentgenol       Date:  2012-11       Impact factor: 3.959

6.  Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies.

Authors:  S Poucell; J Ireton; P Valencia-Mayoral; E Downar; L Larratt; J Patterson; L Blendis; M J Phillips
Journal:  Gastroenterology       Date:  1984-05       Impact factor: 22.682

7.  Increased hepatic density and phospholipidosis due to amiodarone.

Authors:  I S Goldman; M L Winkler; S E Raper; M E Barker; E Keung; H I Goldberg; T D Boyer
Journal:  AJR Am J Roentgenol       Date:  1985-03       Impact factor: 3.959

8.  Liver necrosis and regeneration after fulminant hepatitis: pathologic correlation with CT and MR findings.

Authors:  T Murakami; R L Baron; M S Peterson
Journal:  Radiology       Date:  1996-01       Impact factor: 11.105

9.  Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Arjang Ruhparwar; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Hugo A Katus; Andreas O Doesch
Journal:  Drug Des Devel Ther       Date:  2017-06-19       Impact factor: 4.162

10.  Amiodarone-induced cirrhosis of liver: what predicts mortality?

Authors:  Nasir Hussain; Anirban Bhattacharyya; Suartcha Prueksaritanond
Journal:  ISRN Cardiol       Date:  2013-03-14
View more
  2 in total

Review 1.  Other types of diffuse liver disease: is there a way to do it?

Authors:  Hilton Leao Filho; Camila Vilela de Oliveira; Natally Horvat
Journal:  Abdom Radiol (NY)       Date:  2020-11

2.  Iodine accumulation of the liver in patients treated with amiodarone can be unmasked using material decomposition from multiphase spectral-detector CT.

Authors:  Kai Roman Laukamp; Simon Lennartz; Ahmad Hashmi; Markus Obmann; Vivian Ho; Nils Große Hokamp; Frank Philipp Graner; Robert Gilkeson; Thorsten Persigehl; Amit Gupta; Nikhil Ramaiya
Journal:  Sci Rep       Date:  2020-04-24       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.